The Motley Fool

Key Data Points

Primary metrics and data points about Amicus Therapeutics, Inc..
Current Price: $13.75
Prev Close: $14.02
Open: $14.04
Bid: $13.00
Ask: $14.00
Day's Range: $13.42 - $14.04
52wk Range: $3.50 - $14.65
Volume: 1,940,920
Avg Vol 2,598,588
Market Cap: $1B
P/E (ttm): -15.08
EPS (ttm): ($0.93)
Div & Yield: $0.00 (0.0%)

Business Summary

Industry, sector and description for Amicus Therapeutics, Inc..

A clinical-stage biopharmaceutical company, which focused on the discovery, development and commercialization of novel small molecule, orally-administered drugs, known as pharmacological chaperones, for the treatment of a range of human genetic diseases.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers

Stock Charting

FOLD vs. SPY | 2 Year Performance
Sponsored by

Company Rating

What our community thinks about Amicus Therapeutics, Inc..
CAPS Rating 2 out of 5
 
103 Outperform
28 Underperform
CAPS All Stars
 
30 Outperform
8 Underperform

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

John F. Crowley, CEO

100% Approve

Based on 7 Ratings

Powered by

More Details about Amicus Therapeutics, Inc.

Primary metrics and data points about Amicus Therapeutics, Inc..